Hematology / Oncology « back to Hematology / Oncology activities
CDK4/6 Inhibitors in HR+/HER2- Breast Cancer: Addressing Barriers to Their Optimal Use
Release Date: April 22, 2022
Expiration Date: April 21, 2023
Not certified for credit.
Download
Program Overview
Program Description
To access the downloadable PowerPoint slide set on CDK4/6 inhibitors in HR+/HER2- breast cancer, please click the download button.
Details
This activity is supported by an educational grant from Lilly.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. PRP4948-PPT